Risperdal Lawsuit Plaintiffs Respond to Defense Bid to Have Some Risperdal Gynecomastia Claims Dismi

The Firm is representing a number of Risperdal lawsuit clients in claims that allege use of the antipsychotic medication caused men and boys to develop gynecomastia (male breast growth). New York, New York (PRWEB) June 23, 2014 Plaintiffs in Risperdal lawsuits (http://www.risperdallawsuitcenter.com/ ) pending in a mass tort litigation in Pennsylvania’s Philadelphia Court of Common Pleas have responded to a defense motion seeking to have some Risperdal gynecomastia claims dismissed on the grounds that they are time-barred. According to court documents, Johnson & Johnson and its Janssen
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories